Article Details

Roche says decision to end camonsertib agreement with Repare Therapeutics was not taken easy

Retrieved on: 2024-02-13 16:37:32

Tags for this article:

Click the tags to see associated articles and topics

Roche says decision to end camonsertib agreement with Repare Therapeutics was not taken easy. View article details on hiswai:

Excerpt

With the return of camonsertib, Repare's deep clinical pipeline consists of four wholly owned synthetic lethal therapies.” Roche said its decision to ...

Article found on: www.outsourcing-pharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up